753 related articles for article (PubMed ID: 30948284)
1. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
Duhig KE; Myers J; Seed PT; Sparkes J; Lowe J; Hunter RM; Shennan AH; Chappell LC;
Lancet; 2019 May; 393(10183):1807-1818. PubMed ID: 30948284
[TBL] [Abstract][Full Text] [Related]
2. Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial.
Hurrell A; Webster L; Sparkes J; Battersby C; Brockbank A; Clark K; Duhig KE; Gill C; Green M; Hunter RM; Seed PT; Vowles Z; Myers J; Shennan AH; Chappell LC;
Lancet; 2024 Feb; 403(10427):619-631. PubMed ID: 38342128
[TBL] [Abstract][Full Text] [Related]
3. Placental growth factor in assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a stepped wedge cluster randomised control trial (PARROT Ireland).
Hayes-Ryan D; Khashan AS; Hemming K; Easter C; Devane D; Murphy DJ; Hunter A; Cotter A; McAuliffe FM; Morrison JJ; Breathnach FM; Dempsey E; Kenny LC; O'Donoghue K;
BMJ; 2021 Aug; 374():n1857. PubMed ID: 34389547
[TBL] [Abstract][Full Text] [Related]
4. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
5. Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2).
Hurrell A; Sparkes J; Duhig K; Seed PT; Myers J; Battersby C; Clark K; Green M; Hunter RM; Shennan AH; Chappell LC; Webster L
Trials; 2022 Sep; 23(1):722. PubMed ID: 36056408
[TBL] [Abstract][Full Text] [Related]
6. Placental Growth Factor informed management of suspected pre-eclampsia or fetal growth restriction: The MAPPLE cohort study.
Sharp A; Chappell LC; Dekker G; Pelletier S; Garnier Y; Zeren O; Hillerer KM; Fischer T; Seed PT; Turner M; Shennan AH; Alfirevic Z
Pregnancy Hypertens; 2018 Oct; 14():228-233. PubMed ID: 29627351
[TBL] [Abstract][Full Text] [Related]
7. PARROT Ireland: Placental growth factor in Assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a Stepped Wedge Cluster Randomised Control Trial Research Study Protocol.
Hayes-Ryan D; Hemming K; Breathnach F; Cotter A; Devane D; Hunter A; McAuliffe FM; Morrison JJ; Murphy DJ; Khashan A; McElroy B; Murphy A; Dempsey E; O'Donoghue K; Kenny LC
BMJ Open; 2019 Mar; 9(2):e023562. PubMed ID: 30826791
[TBL] [Abstract][Full Text] [Related]
8. Placental growth factor testing for suspected pre-eclampsia: a cost-effectiveness analysis.
Duhig KE; Seed PT; Myers JE; Bahl R; Bambridge G; Barnfield S; Ficquet J; Girling JC; Khalil A; Shennan AH; Chappell LC; Hunter RM
BJOG; 2019 Oct; 126(11):1390-1398. PubMed ID: 31240854
[TBL] [Abstract][Full Text] [Related]
9. A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and/or fetal growth restriction.
Ormesher L; Johnstone ED; Shawkat E; Dempsey A; Chmiel C; Ingram E; Higgins LE; Myers JE
Pregnancy Hypertens; 2018 Oct; 14():234-239. PubMed ID: 29559205
[TBL] [Abstract][Full Text] [Related]
10. Placental Growth Factor (PlGF)- Based Biomarker Testing to Help Diagnose Pre-eclampsia in People With Suspected Pre-eclampsia: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2023; 23(3):1-146. PubMed ID: 37284279
[TBL] [Abstract][Full Text] [Related]
11. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?
Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
[TBL] [Abstract][Full Text] [Related]
13. Placental growth factor measurements in the assessment of women with suspected Preeclampsia: A stratified analysis of the PARROT trial.
Duhig KE; Myers JE; Gale C; Girling JC; Harding K; Sharp A; Simpson NAB; Tuffnell D; Seed PT; Shennan AH; Chappell LC
Pregnancy Hypertens; 2021 Mar; 23():41-47. PubMed ID: 33221705
[TBL] [Abstract][Full Text] [Related]
14. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
[TBL] [Abstract][Full Text] [Related]
15. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.
Salahuddin S; Wenger JB; Zhang D; Thadhani R; Karumanchi SA; Rana S
Hypertens Pregnancy; 2016 Aug; 35(3):330-45. PubMed ID: 27028795
[TBL] [Abstract][Full Text] [Related]
16. Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study.
Gaccioli F; Sovio U; Cook E; Hund M; Charnock-Jones DS; Smith GCS
Lancet Child Adolesc Health; 2018 Aug; 2(8):569-581. PubMed ID: 30119716
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three commercially available placental growth factor-based tests in women with suspected preterm pre-eclampsia: the COMPARE study.
McCarthy FP; Gill C; Seed PT; Bramham K; Chappell LC; Shennan AH
Ultrasound Obstet Gynecol; 2019 Jan; 53(1):62-67. PubMed ID: 29575304
[TBL] [Abstract][Full Text] [Related]
18. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial.
Chappell LC; Brocklehurst P; Green ME; Hunter R; Hardy P; Juszczak E; Linsell L; Chiocchia V; Greenland M; Placzek A; Townend J; Marlow N; Sandall J; Shennan A;
Lancet; 2019 Sep; 394(10204):1181-1190. PubMed ID: 31472930
[TBL] [Abstract][Full Text] [Related]
19. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.
Frampton GK; Jones J; Rose M; Payne L
Health Technol Assess; 2016 Nov; 20(87):1-160. PubMed ID: 27918253
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Performance of Placental Growth Factor in Women With Suspected Preeclampsia Attending Antenatal Facilities in Maputo, Mozambique.
Ukah UV; Mbofana F; Rocha BM; Loquiha O; Mudenyanga C; Usta M; Urso M; Drebit S; Magee LA; von Dadelszen P
Hypertension; 2017 Mar; 69(3):469-474. PubMed ID: 28137987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
